Home » Topics » Briefs » Other news to note

Other news to note
RSS

Other news to note for Jan. 10, 2020

Jan. 10, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 10, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 9, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 9, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 8, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 8, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 7, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 7, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 7, 2020

Biopharma happenings in Asia-Pacific, including deals and partnerships, grants, preclinical data and other news in brief.

Jan. 6, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...